Inventory
For SaulGroup’s inventory of Product X, the income recognition treatment in 2016 and 2017 shows notable differences under IFRS and U.S. GAAP. IFRS mandates the use of the lower of cost or net realizable value for inventory measurement (IFRS, 2023). Thus, for 2016, SaulGroup would report an inventory value of $750,000 (the net realizable value of $850,000 minus the $100,000 in completion and selling costs), resulting in a loss of $250,000. In contrast, U.S. GAAP requires inventory to be reported at the lower of cost or market, with the market value not exceeding net realizable value nor less than net realizable value less a normal profit margin (EY, 2021). Therefore, the market value is $680,000, which results in a larger loss of $320,000 in 2016.
In 2017, the completion cost was $90,000, and the selling price was $870,000; hence, the profit was $780,000 under both U.S. GAAP and IFRS. SaulGroup reports this as income in 2017 since the inventory was sold. The variances in initial inventory valuation under both accounting standards ripple through reported income, total assets, and shareholders’ equity (EY, 2021). IFRS shows a smaller loss in 2016 and thus higher income, assets, and equity than U.S. GAAP. These differences reversed in 2017, when the income and total assets reported under U.S. GAAP increased, as the product’s sales offset the previously reported loss.
Plant, Property, and Equipment
SaulGroup acquired equipment on January 2, 2016, for $5 million, which depreciates over a five-year lifespan using the straight-line method, with no residual value anticipated. Under IFRS, if the company opts for the revaluation model, the equipment’s upward revaluation in 2018 to $6 million would increase assets and equity by $1 million, excluding depreciation (IFRS, 2023). However, such a gain would not flow through to profit or loss but would instead be recognized in other comprehensive income, thereby increasing equity through revaluation surplus. The subsequent depreciation charge would be higher due to the increased carrying amount.
Under U.S. GAAP, revaluation of equipment, plant, and property is not permitted after initial recognition (EY, 2021). The equipment remains on the books at its historical cost – less accumulated depreciation. As a result, SaulGroup’s income statement would not reflect any revaluation gain in 2018, and the depreciation expense from 2016 to 2020 would remain consistent.
The distinction between IFRS and U.S. GAAP regarding this equipment results in differences in the reported figures for stockholders’ equity, total assets, and income. IFRS allows for the recognition of increases in the fair value of assets; however, U.S. GAAP maintains a historical cost approach that does not adjust for such changes in fair value (EY, 2021). The difference in asset valuation and equity under the two standards underscores the divergent principles governing the frameworks – fair value versus historical cost.
Research and Development
SaulGroup invested $1 million in the development of Product Y in 2016. Under IFRS, SaulGroup recognized $300,000 as an intangible asset, reflecting the portion attributable to development costs meeting the IAS 38 criteria. The recognition allowed the company to capitalize on the costs and amortize them over the product’s useful life, thereby mitigating the immediate impact on 2016 income.
However, U.S. GAAP does not permit capitalization in the same manner (EY, 2021). Instead, the entire amount spent on research and development must be expensed in the period in which it is incurred. This difference led to higher expense recognition under U.S. GAAP in 2016; as a result, SaulGroup’s net income is lower under IFRS.
Starting January 2, 2017, with the availability of Product Y for sale, SaulGroup began amortizing the capitalized development costs under IFRS. The amortization expense, spread over the expected five-year sales period, tempered the income effects annually. Under U.S. GAAP, with the $1 million already expensed, no further R&D expenses affected the 2017 income – it provides a boost to the year’s net income in comparison to IFRS. The distinction between the two frameworks accounted for the disparity in reported stockholders’ equity, asset values, and income.
Intangible Assets
In 2016, SaulGroup faced an impairment assessment for a brand acquired two years prior. The brand, valued at $100,000 at acquisition, now has an estimated selling price of $80,000. However, IFRS guidelines require impairment tests to rely on recoverable amount calculations, which are the higher of fair value less costs to sell and value in use (EY, 2021). Here, the value in use, calculated as the present value of future cash flows, was $70,000. If IFRS is applied, SaulGroup would recognize an impairment loss of $30,000, reducing the brand’s carrying amount to $70,000. The loss would decrease income and total assets, while stockholders’ equity would also fall by the loss amount.
Under U.S. GAAP, the impairment testing focuses on whether the carrying amount of the asset is not recoverable through the sum of the undiscounted future cash flows. Given that the expected future cash flows are $120,000, which exceeds the brand’s carrying amount, no impairment loss would be recognized. SaulGroup’s financial statements would exhibit higher stockholders’ equity, assets, and income in 2016 than under IFRS. The variance between the two sets of standards stems from the different approaches to measuring impairment (EY, 2021). One should note the distinction between discounted cash flows under IFRS and undiscounted cash flows under U.S. GAAP.
References
EY. (2021). US GAAP versus IFRS.
IFRS. (2023). Supporting materials for IFRS accounting standards.